Press & News

ViewReleaseInStandardHtml

Chairman of Boule Diagnostics resigns

Following Boule’s former majority shareholder Siem Capital AB selling all of its shares in the company in December 2015, the Chairman of the Board, Lars-Olof Gustavsson, who was appointed as a Board member on the mandate of the former majority shareholder, notified the company yesterday that he was resigning as both the Chairman and as a Board member. A Board meeting was held yesterday, at which the Board member Peter von Ehrenheim was selected as the new Chairman until the Annual General Meeting.

The Board has also decided to call in Jon Risfelt to Boule’s Board of Directors until the Annual General Meeting. Jon Risfelt (born 1961) was the former CEO of companies such as Europolitan and Gambro Renal. Jon is the Chairman of the Board of Bisnode AB, Dialect AB and Smartfish AS, and a Board member of companies such as Bilia AB and Ticket Business Travel AB.

For more information, please contact:

Peter von Ehrenheim, Chairman of Boule Diagnostics AB, tel. +46(0)70-667 57 11

About Boule Diagnostics AB (publ)

Boule Diagnostics AB is a rapidly growing diagnostics company that develops, manufactures and markets systems and consumables for blood cell counts (hematology) to outpatient care. The company is primarily oriented to small and medium sized hospitals, clinics and laboratories within outpatient care, and to other diagnostics companies within both human and veterinary hematology. The company operates via subsidiary companies in Sweden, USA and China. Boule Diagnostics shares have been listed on the NASDAQ Stockholm Exchange since 2011. Additional information about Boule can be found at www.boule.se.

Boule Diagnostics AB is required to publish the information in this press release by the Swedish Securities Markets Act and/or the Financial Instruments Trading Act. The information is embargoed for publication until 08:45 (CET) on January 26, 2016.